Dark Marks After Pimples: Why They Happen and How to Actually Fade Them

You had a pimple. It went away three weeks ago. What is left behind is a flat brown or reddish spot that has not faded, refuses to hide under makeup, and is starting to feel more permanent than the pimple ever was.

This is one of the most common complaints among Indian skin. It is also one of the most misunderstood. People treat these marks as scars and give up. Or they attack them with harsh actives and make them worse. Or they cover them with concealer for months, hoping they will disappear on their own, which they eventually do, but slowly, and not before the next pimple leaves a fresh one.

What you are looking at is not a scar. It is post-inflammatory hyperpigmentation (PIH), and it is a biological process, not damaged tissue. Your skin made extra melanin in response to the inflammation from the pimple, deposited it in the upper layers, and now that pigment has to work its way out. Understanding why this happens, why it happens more intensely on Indian skin than on lighter skin, and what actually accelerates the fading process is the difference between marks that fade in three months and marks that persist for a year.

This article explains the biology of PIH, why Fitzpatrick III-V skin is uniquely susceptible, the difference between marks and scars (a critical distinction that changes what you can actually do), the ingredients with real evidence for fading marks, what accelerates versus prevents fading, and a realistic timeline for what to expect.

Marks Versus Scars: The Distinction That Matters Most

Before anything else, the single most important distinction: what you have on your face after a pimple heals is either a mark or a scar, and the two are fundamentally different conditions with fundamentally different treatments.

A mark is pigment. The skin surface is smooth. If you run your finger over it with your eyes closed, you cannot feel it. It is only visible because there is more melanin in the epidermis (and sometimes upper dermis) at that spot than in the surrounding skin. Under the right conditions, and with time, that melanin migrates upward with normal skin cell turnover and is shed. The mark fades.

A scar is structural damage. The skin surface has texture change: it may be depressed (atrophic, "ice pick" or "boxcar" scarring), raised (hypertrophic), or have visible ridging. The dermis itself has been remodelled, with collagen either destroyed or overproduced. No topical product will restore the original structure. Scars respond only to procedural interventions: microneedling, chemical peels, subcision, laser resurfacing, or in severe cases, punch excision.^[1]

The reason this distinction matters so much: the wrong approach makes things worse. Treating a mark like a scar (aggressive procedures on an intact epidermis) causes new inflammation, which causes new PIH, which is exactly what you were trying to fade. Treating a scar like a mark (topical brightening actives on remodelled dermis) delivers zero result and wastes months of consistent application.

The finger test. Wash your face. Close your eyes. Run a fingertip lightly across the spot. If you feel no texture change compared to the surrounding skin, it is a mark. If you feel a dip, a raised bump, or any surface irregularity, it is a scar. This costs nothing, takes ten seconds, and tells you everything about which category of treatment applies.^[1]

The rest of this article is about marks. If you have scars, a dermatologist consultation is the next step, and no article can substitute for that.

Why Indian Skin Makes More Marks

The frustration is real: your friend with lighter skin gets a pimple, it heals, no mark. You get the same pimple, and the mark is still there four months later. This is not perception, it is documented biology.^[2][3]

Fitzpatrick skin types III-VI, which includes most Indian skin, have three structural differences from Fitzpatrick I-II skin that make PIH more likely, more intense, and longer-lasting.^[3][4]

Larger melanocytes with more active melanosomes. The melanin-producing cells in darker skin are physically larger and produce more melanosomes (the pigment packages that melanocytes make and then transfer to surrounding skin cells). Same inflammatory signal, more pigment output.

Greater melanocyte reactivity to inflammatory signals. The upregulation of melanocyte-stimulating pathways in response to inflammatory mediators is stronger in Fitzpatrick III-VI skin. Cytokines and chemokines released during a pimple's inflammatory phase produce a larger melanocyte response than they would in lighter skin.^[2]

More efficient melanosome transfer. Once melanin is made, melanosomes have to travel from the melanocyte to the surrounding keratinocytes. This transfer is more efficient in darker skin, meaning more of the melanin that is produced actually ends up deposited in the visible skin layers rather than staying inside the melanocyte.

The net result: for the same inflammatory event, Indian skin produces significantly more visible pigmentation than European skin. The incidence of PIH in individuals with darker skin tones with acne can be as high as 65%.^[5] This is not something you can change. It is your baseline biology, and any strategy that fails to account for it is going to disappoint you.

What Actually Happens: The PIH Cascade

PIH is not passive staining. It is an active biological response with a specific sequence, and every mark on your face has followed this exact sequence.^[6]

Step 1: Inflammation. The pimple activates the immune system. Immune cells arrive at the site, releasing signalling molecules called cytokines, chemokines, and reactive oxygen species (ROS). These are useful for fighting the infection but they do not stay in the pimple. They diffuse into the surrounding tissue.

Step 2: Melanocyte activation. Melanocytes in the vicinity have receptors that respond to inflammatory signalling. When those signals arrive, the melanocytes upregulate the enzyme tyrosinase, which is the rate-limiting step in melanin production. More tyrosinase means more melanin. Simultaneously, arachidonic acid metabolites released during inflammation, particularly prostaglandins and leukotrienes, act directly as melanogenic stimuli.^[7]

Step 3: Melanin overproduction. The activated melanocytes ramp up melanin synthesis, packaging it into melanosomes. This continues for as long as the inflammatory signal persists, which is often days after the pimple itself has visibly resolved.

Step 4: Melanosome transfer. Melanocytes transfer their melanosomes to the surrounding keratinocytes, the skin cells that make up most of the epidermis. The keratinocytes now contain visible pigment. This is what you see as the mark.

Step 5: Mark visible. The pigment has reached the visible layers of the skin. From here, fading depends on epidermal turnover: the natural cycle by which skin cells rise from the deeper layers to the surface and are shed. In healthy adult skin, this cycle takes 28-40 days.

Understanding this cascade is what makes the ingredient recommendations that follow meaningful. Every active with real evidence for fading PIH works by interrupting one specific step. Niacinamide interrupts step 4 (melanosome transfer). Tranexamic acid interrupts step 2 (melanocyte activation). Vitamin C interrupts step 3 (melanin synthesis). Retinoids accelerate step 5 (cell turnover). No single ingredient works at every step, which is why the strongest protocols combine ingredients that target different steps.^[8]

Why Marks Fade Slower Than You Expect

The single most common reason people give up on fading PIH is that they underestimate how long the biological process actually takes. Two facts that are worth internalising before you start any protocol.

Epidermal turnover is 28-40 days in healthy adult skin. Once melanin is deposited in a keratinocyte, that keratinocyte has to travel from the basal layer of the epidermis to the surface and be shed. Even in ideal conditions, this is a 4-6 week process for any given cell.^[9] Multiple cycles are needed to visibly clear a mark, because not all pigmented cells are at the same stage of maturity when treatment begins.

Turnover slows with age. In your twenties, epidermal turnover completes in about 28 days. In your thirties, it slows to 35 days. In your forties, closer to 45 days. This is one of many reasons the same PIH mark fades faster in a twenty-year-old than in a forty-year-old, even with identical treatment.^[9]

Practical implication: any protocol needs at least 8-12 weeks of consistent application before you can honestly assess whether it is working. Assessing at 4 weeks is assessing before biology has had a chance to respond. Assessing at 4 days is not assessment, it is anxiety.

Ingredients With Real Evidence

The market for hyperpigmentation products is saturated with actives that have thin or nonexistent clinical support. Four ingredients have substantive evidence for fading PIH specifically. Each one targets a different step of the cascade, which is why the strongest protocols use combinations rather than single actives.^[8][10]

Niacinamide

Niacinamide inhibits melanosome transfer from melanocytes to keratinocytes by 35-68% in vitro. In clinical trials, topical niacinamide has shown reduced hyperpigmentation and improved skin tone with consistent twice-daily use.^[11] The mechanism is precise: niacinamide does not stop melanin production, it stops made melanin from reaching the visible skin layers. This makes it particularly useful for preventing new PIH from becoming visible during active breakout periods.

Effective concentrations sit in the 2-5% range. Higher concentrations (10%, which has become common in Indian D2C serums) have not been shown to produce proportionally larger benefits and are associated with more irritation, particularly during active barrier stress.^[11]

Tranexamic Acid

Tranexamic acid works upstream of most other actives. It blocks the plasminogen activation pathway that stimulates melanocytes in the first place. In response to UV or inflammation, keratinocytes produce plasmin, which triggers the release of arachidonic acid, which becomes the prostaglandins that stimulate melanocytes to make melanin. Tranexamic acid interrupts this at the plasmin step. It also reduces tyrosinase activity directly, likely because its molecular structure is similar to tyrosine.^[12][13]

Topical concentrations of 2-5% have shown clinical efficacy for both melasma and PIH. Notably, a 3% topical formulation has been shown to have efficacy comparable to the standard prescription depigmenting agents with a better safety profile.^[14] Tranexamic acid is particularly promising for PIH because it addresses the upstream activation step, which means it also helps prevent new marks from forming, not just fade existing ones.

Vitamin C (L-Ascorbic Acid)

Vitamin C inhibits tyrosinase, the rate-limiting enzyme in melanin production. It also acts as an antioxidant, neutralising the reactive oxygen species released during inflammation that would otherwise stimulate melanocytes. This dual action makes it useful for both fading existing marks and preventing new ones, particularly in high-pollution environments like Indian cities.^[8]

Effective concentrations sit at 10-20% L-ascorbic acid. Vitamin C is famously unstable in formulation, which means the quality of the product and its packaging matter as much as the concentration on the label. Look for anhydrous formulations, opaque or airless packaging, and pH below 3.5.

Retinoids

Retinoids accelerate epidermal turnover, which means pigmented cells reach the surface and are shed faster than they would through natural turnover alone. They also have direct effects on melanocyte activity. Topical retinoids are consistently cited across systematic reviews as a first-line intervention for PIH in Fitzpatrick III-VI skin.^[8][15]

There is a caveat, however. Retinoids are barrier-disruptive during the initial weeks of use, and barrier disruption itself triggers inflammation, which can trigger fresh PIH. In Indian skin specifically, retinoids should be introduced slowly (twice weekly, building to daily over 6-8 weeks) and only alongside a stable, barrier-supportive base routine. Skipping this step is one of the most common reasons Indian users abandon retinoids or make their marks worse.

The Prerequisite Everyone Underestimates: Sunscreen

Photoprotection is the cornerstone of PIH management, cited by every systematic review of hyperpigmentation treatment as the single most important intervention regardless of what active you layer on top.^[16] Without it, no brightening protocol works. The reason is mechanical.

UV exposure at any point during your fading protocol reactivates the melanocyte-stimulating pathways that caused the PIH in the first place. UV directly upregulates tyrosinase, triggers α-MSH signalling, and restarts melanin overproduction in exactly the same cells you are trying to quiet down.^[6][16] Skip sunscreen for two weeks in the middle of a niacinamide protocol and you have effectively pressed reset on your progress.

For Indian skin dealing with PIH, this means broad-spectrum SPF 30 minimum every single morning, applied generously (two finger lengths for face and neck), reapplied every 2-3 hours during outdoor exposure, and not skipped on cloudy days or when you are indoors near windows. Iron oxides in the sunscreen formulation are worth looking for specifically, because they protect against visible light in addition to UV, and visible light also stimulates pigmentation in Fitzpatrick III-VI skin.

This is the least glamorous part of any PIH protocol, and it is the part with the largest evidence base. If you have to choose one thing to be consistent about, it is not the brightening serum. It is the sunscreen.

The Prevention Layer: Barrier Health

The best time to address PIH is before it forms, and the mechanism for that is barrier support. Fresh inflammation creates fresh PIH. Any active or product that inflames your skin, whether that is a harsh cleanser, an over-aggressive exfoliant, or an active introduced too fast, creates the exact inflammatory conditions that stimulate melanocytes to overproduce melanin.^[6]

A stable, well-supported skin barrier reduces baseline inflammation. Cleansers that maintain skin pH at 4.5-5.5 and avoid SLS-based surfactants prevent the low-grade barrier damage that would otherwise become the fuel for the next inflammatory cycle. Moisturisers with niacinamide and glycerin support ceramide biosynthesis, which strengthens the barrier's ability to withstand daily insults without triggering an inflammatory response.^[11]

The Glycophil Skin Essentials Cleanser is built around this: SLS-free, pH 5.0-5.5, with niacinamide at 2%. The Glycophil Skin Essentials Daily Moisturiser layers niacinamide at 1% with glycerin for barrier support during the high-TEWL hours of an Indian day. Together, they form the barrier-supportive foundation on which brightening actives can actually work. Adding a vitamin C serum on top of a damaged, inflamed barrier is fighting yourself. Getting the barrier right first is not a delay to your PIH protocol, it is the enabling condition for it.

For deeper barrier support during recovery from a particularly inflammatory breakout period, the Glycophil Skin Essentials Intensive Moisturiser layered as the PM step provides D-Panthenol at 10% and skin-cofactor minerals that support the overnight repair window when your skin does most of its recovery work.

What Accelerates Versus Slows Fading

Two items from the "slows fading" column deserve specific attention because they are the most common self-inflicted mistakes on Indian skin.

Lemon juice and DIY treatments are worth calling out because they are widely recommended in Indian household skincare tradition and they are actively harmful. Lemon juice has a pH of 2-3, which is aggressively acidic. Applied to Indian skin, particularly to the sensitised skin around a healing pimple, it causes chemical burns and, because your skin then treats the burn as a fresh inflammatory event, produces more PIH than the original pimple. Apple cider vinegar, toothpaste, baking soda, and every other kitchen-sink remedy operate on similar principles and produce similar results.

Switching products every 2-3 weeks is the biggest self-sabotage in PIH protocols. Because the underlying biology takes 8-12 weeks to show visible response, any active you use for less than that has not had a chance to work. When you switch, you reset the clock. The 8-12 week timeline is not a marketing figure. It is the epidermal turnover biology of your own skin.^[9]

Realistic Timeline

Setting expectations is part of what makes a PIH protocol actually work. The most common failure mode is impatience at week 4, when biology has not yet had time to respond.

A subset of marks will not fade on this timeline: marks that are grey or ashen rather than brown, marks that have been present for more than 12 months without any fading, and marks that follow cystic acne or deep trauma. These may have dermal involvement (pigment deposited in the deeper layer of the skin, past the reach of topical actives) and warrant a dermatologist consultation.^[1] No brightening protocol will reach dermal PIH effectively.

A Realistic PIH Protocol

Combining what has evidence and what is honest about what Glycophil currently makes:

The Prevention Foundation (What Glycophil Provides)

AM: Cleanser → Daily Moisturiser → SPF 30+ with broad-spectrum coverage. The Daily Moisturiser's niacinamide contributes to melanosome-transfer inhibition throughout the day.

PM: Cleanser → Intensive Moisturiser. Overnight barrier repair reduces the baseline inflammation that would otherwise fuel new PIH.

This foundation prevents new marks from forming and provides the barrier stability needed to safely introduce brightening actives.

Adding Brightening Actives (What Glycophil Does Not Currently Make)

For fading existing marks, layer one brightening active into the routine above. Choose based on which mechanism you want to target:

If your marks are recurring from ongoing breakouts: Look for a topical tranexamic acid product (3-5%). It works upstream and prevents new pigmentation from taking hold. Apply PM, after cleansing, before Intensive Moisturiser.

If your marks are largely stable and you want to actively fade them: Look for a stable L-ascorbic acid serum (10-20%). It inhibits melanin production directly and provides antioxidant support against pollution-driven pigmentation. Apply AM, after cleansing, before Daily Moisturiser and SPF.

If your marks are deep and stubborn: Consider prescription-strength topical retinoids under dermatologist supervision. Introduce slowly, twice weekly for the first month, and never without the barrier foundation above already in place for at least 4 weeks first.

Glycophil's forthcoming depigmentation cream is built around tranexamic acid as the primary upstream active, layered with alpha arbutin, kojic acid, and lactic acid for a multi-mechanism approach. Glycophil's forthcoming acne line is built around azelaic acid, tranexamic acid, niacinamide, and zinc PCA, ingredients with published evidence for both acne control and PIH prevention. Both lines follow the same principle as the Adaptive Pack: barrier-first foundation, mechanism-targeted actives, honest concentrations. Neither is currently available, and the recommendations elsewhere in this article stand for anyone who wants to start today.

When to See a Dermatologist

Not every mark is a job for topical products. See a dermatologist if:

The mark has been present for more than 12 months with no visible fading despite consistent protocol adherence. This suggests possible dermal involvement.

The mark is grey, blue-grey, or ashen rather than brown. Dermal PIH does not respond to topical brightening actives.

You have any texture change at the mark: depression, elevation, ridging. This is scarring, not PIH, and needs procedural intervention.

You are unsure whether what you have is PIH or something else (post-inflammatory erythema, which is red rather than brown; melasma, which is patchy rather than spot-based; drug-induced hyperpigmentation). Correct diagnosis is prerequisite to correct treatment.

You have widespread PIH affecting large areas of the face, particularly following severe acne. Combination therapy under supervision produces better results than layered self-treatment.

Frequently Asked Questions

Glycophil Skin Essentials Adaptive Pack

The barrier-supportive foundation on which any PIH protocol has to sit. Cleanser, Daily Moisturiser, Intensive Moisturiser. Niacinamide throughout the routine for melanosome-transfer support. AM defence, PM repair, adaptive when your skin needs more. Get this stable first, then layer targeted brightening actives.

Add to Cart · Rs. 799

Free shipping across India · Dermatologically tested · Made in India

Related reading: Pimples on Face: A Complete Guide · Dark Spots and Hyperpigmentation · What a Damaged Skin Barrier Actually Looks Like · How Sunscreen Actually Works on Indian Skin

References

1. Park JY, Park JH, Kim SJ, et al. Two histopathological patterns of postinflammatory hyperpigmentation: epidermal and dermal. J Cutan Pathol. 2017;44(2):118-124. PubMed: 27682596.
2. Markiewicz E, Karaman-Jurukovska N, Mammone T, Idowu OC. Post-inflammatory hyperpigmentation in dark skin: molecular mechanism and skincare implications. Clin Cosmet Investig Dermatol. 2022;15:2555-2565. PubMed: 36466945.
3. Grimes PE. Management of hyperpigmentation in darker racial ethnic groups. Semin Cutan Med Surg. 2009;28(2):77-85. PubMed: 19608057.
4. Taylor SC, Grimes PE, Lim J, Im S, Lui H. Postinflammatory hyperpigmentation. J Cutan Med Surg. 2009;13(4):183-191. PubMed: 19706226.
5. Mar K, Khalid B, Maazi M, et al. Treatment of post-inflammatory hyperpigmentation in skin of colour: a systematic review. J Cutan Med Surg. 2024;28(5):473-486. PubMed: 39075672.
6. Maghfour J, Olayinka J, Hamzavi IH, Mohammad TF. A focused review on the pathophysiology of post-inflammatory hyperpigmentation. Pigment Cell Melanoma Res. 2022;35(3):320-327. PubMed: 35192245.
7. Tomita Y, Maeda K, Tagami H. Melanocyte-stimulating properties of arachidonic acid metabolites: possible role in postinflammatory pigmentation. Pigment Cell Res. 1992;5(5 Pt 2):357-361. PubMed: 1292013.
8. Li Y, Li M, Wang J, et al. Post-inflammatory hyperpigmentation: molecular mechanisms and advances in dermocosmetic management. J Cosmet Dermatol. 2026. DOI: 10.1111/jocd.70738.
9. Iizuka H. Epidermal turnover time. J Dermatol Sci. 1994;8(3):215-217. PubMed: 7865480.
10. Kashetsky N, Feschuk A, Pratt ME. Post-inflammatory hyperpigmentation: a systematic review of treatment outcomes. J Eur Acad Dermatol Venereol. 2024;38(3):470-479. PubMed: 37991074.
11. Hakozaki T, Minwalla L, Zhuang J, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002;147(1):20-31. PubMed: 12100180.
12. Maeda K, Tomita Y. Mechanism of the inhibitory effect of tranexamic acid on melanogenesis in cultured human melanocytes in the presence of keratinocyte-conditioned medium. J Health Sci. 2007;53(4):389-396.
13. Kim SJ, Park JY, Shibata T, Fujiwara R, Kang HY. Efficacy and possible mechanisms of topical tranexamic acid in melasma. Clin Exp Dermatol. 2016;41(5):480-485. PubMed: 27087564.
14. Kanechorn Na Ayuthaya P, Niumphradit N, Manosroi A, Nakakes A. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial. J Cosmet Laser Ther. 2012;14(3):150-154. PubMed: 22506692.
15. Kligman AM, Willis I. A new formula for depigmenting human skin. Arch Dermatol. 1975;111(1):40-48. PubMed: 1119822.
16. Silpa-Archa N, Kohli I, Chaowattanapanit S, Lim HW, Hamzavi I. Postinflammatory hyperpigmentation: a comprehensive overview: epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique. J Am Acad Dermatol. 2017;77(4):591-605. PubMed: 28917451.